| 0 |
RENAL CANCER RECURRENT |
1 |
0.0068 |
| 1 |
CHEMICAL INJURY |
4 |
0.0049 |
| 2 |
CAUSTIC INJURY |
1 |
0.0032 |
| 3 |
SERUM SEROTONIN INCREASED |
1 |
0.0028 |
| 4 |
CHEMICAL BURN |
2 |
0.0017 |
| 5 |
NEURODEGENERATIVE DISORDER |
1 |
0.0016 |
| 6 |
OROMANDIBULAR DYSTONIA |
1 |
0.0014 |
| 7 |
CAUDA EQUINA SYNDROME |
1 |
0.0013 |
| 8 |
APPLICATION SITE BURN |
6 |
0.0012 |
| 9 |
HYPOGONADISM |
1 |
0.0010 |
| 10 |
APPLICATION SITE WARMTH |
1 |
0.0008 |
| 11 |
MENISCUS LESION |
1 |
0.0007 |
| 12 |
NEPHRECTOMY |
1 |
0.0007 |
| 13 |
ANGIOPLASTY |
1 |
0.0007 |
| 14 |
SPINAL DEFORMITY |
1 |
0.0006 |
| 15 |
INCORRECT STORAGE OF DRUG |
1 |
0.0006 |
| 16 |
BURNS SECOND DEGREE |
1 |
0.0006 |
| 17 |
MYELOPATHY |
1 |
0.0005 |
| 18 |
TORTICOLLIS |
1 |
0.0005 |
| 19 |
REACTION TO DRUG EXCIPIENTS |
1 |
0.0005 |
| 20 |
CHEMICAL BURN OF SKIN |
1 |
0.0004 |
| 21 |
NECK INJURY |
1 |
0.0003 |
| 22 |
FIBROSIS |
1 |
0.0003 |
| 23 |
NON-CARDIAC CHEST PAIN |
1 |
0.0003 |
| 24 |
SKIN EROSION |
1 |
0.0003 |
| 25 |
THERMAL BURN |
2 |
0.0003 |
| 26 |
APPLICATION SITE PAIN |
6 |
0.0003 |
| 27 |
PARADOXICAL DRUG REACTION |
1 |
0.0003 |
| 28 |
EXPIRED DRUG ADMINISTERED |
1 |
0.0002 |
| 29 |
VEIN DISORDER |
1 |
0.0002 |
| 30 |
BLEPHAROSPASM |
1 |
0.0002 |
| 31 |
CROHN'S DISEASE |
1 |
0.0001 |
| 32 |
APPLICATION SITE REACTION |
1 |
0.0001 |
| 33 |
DERMATITIS BULLOUS |
1 |
0.0001 |
| 34 |
INADEQUATE ANALGESIA |
1 |
0.0001 |
| 35 |
SKIN SWELLING |
1 |
0.0001 |
| 36 |
FACIAL PAIN |
1 |
0.0001 |
| 37 |
PERSONALITY CHANGE |
1 |
0.0001 |
| 38 |
NERVE INJURY |
1 |
0.0001 |
| 39 |
MALNUTRITION |
1 |
0.0001 |
| 40 |
ILEUS |
1 |
0.0001 |
| 41 |
APPLICATION SITE IRRITATION |
1 |
0.0001 |
| 42 |
SECRETION DISCHARGE |
1 |
0.0001 |
| 43 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 44 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 45 |
BRONCHOSPASM |
1 |
0.0001 |
| 46 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 47 |
SENSORY DISTURBANCE |
1 |
0.0001 |
| 48 |
BLOOD POTASSIUM INCREASED |
1 |
0.0001 |
| 49 |
PSYCHOMOTOR HYPERACTIVITY |
1 |
0.0001 |
| 50 |
SCAR |
1 |
0.0001 |
| 51 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 52 |
THIRST |
1 |
0.0001 |
| 53 |
BONE DISORDER |
1 |
0.0001 |
| 54 |
THINKING ABNORMAL |
1 |
0.0001 |
| 55 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 56 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 57 |
GLAUCOMA |
1 |
0.0001 |
| 58 |
HERNIA |
1 |
0.0001 |
| 59 |
DISABILITY |
1 |
0.0001 |
| 60 |
EATING DISORDER |
1 |
0.0000 |
| 61 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
0.0000 |
| 62 |
APPLICATION SITE PRURITUS |
1 |
0.0000 |
| 63 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 64 |
SKIN ULCER |
1 |
0.0000 |
| 65 |
PHARMACEUTICAL PRODUCT COMPLAINT |
1 |
0.0000 |
| 66 |
APPLICATION SITE ERYTHEMA |
1 |
0.0000 |
| 67 |
PAIN OF SKIN |
1 |
0.0000 |
| 68 |
RASH PRURITIC |
2 |
0.0000 |
| 69 |
MOOD ALTERED |
1 |
0.0000 |
| 70 |
BLISTER |
2 |
0.0000 |
| 71 |
DYSSTASIA |
1 |
0.0000 |
| 72 |
BONE PAIN |
2 |
0.0000 |
| 73 |
HEAD INJURY |
1 |
0.0000 |
| 74 |
SKIN DISORDER |
1 |
0.0000 |
| 75 |
NEOPLASM MALIGNANT |
2 |
0.0000 |
| 76 |
BURNING SENSATION |
2 |
0.0000 |
| 77 |
SKIN BURNING SENSATION |
2 |
0.0000 |
| 78 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 79 |
OSTEOPOROSIS |
1 |
0.0000 |
| 80 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 81 |
SKIN IRRITATION |
1 |
0.0000 |
| 82 |
CELLULITIS |
1 |
0.0000 |
| 83 |
DEPRESSED MOOD |
1 |
0.0000 |
| 84 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 85 |
EYE PAIN |
1 |
0.0000 |
| 86 |
CATARACT |
1 |
0.0000 |
| 87 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 88 |
AMNESIA |
1 |
0.0000 |
| 89 |
SWELLING FACE |
1 |
0.0000 |
| 90 |
RENAL FAILURE |
2 |
0.0000 |
| 91 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 92 |
ERYTHEMA |
3 |
0.0000 |
| 93 |
CHEST PAIN |
2 |
0.0000 |
| 94 |
MIGRAINE |
1 |
0.0000 |
| 95 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 96 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 97 |
SYNCOPE |
1 |
0.0000 |
| 98 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
2 |
0.0000 |
| 99 |
ASTHMA |
1 |
0.0000 |
| 100 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 101 |
JOINT SWELLING |
1 |
0.0000 |
| 102 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 103 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 104 |
HYPERHIDROSIS |
1 |
0.0000 |
| 105 |
INSOMNIA |
2 |
0.0000 |
| 106 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 107 |
RASH |
3 |
0.0000 |
| 108 |
MALAISE |
3 |
0.0000 |
| 109 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 110 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 111 |
PARAESTHESIA |
1 |
0.0000 |
| 112 |
DRUG INTERACTION |
1 |
0.0000 |
| 113 |
MYALGIA |
1 |
0.0000 |
| 114 |
MUSCLE SPASMS |
1 |
0.0000 |
| 115 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 116 |
ASTHENIA |
2 |
0.0000 |
| 117 |
ANAEMIA |
1 |
0.0000 |
| 118 |
SOMNOLENCE |
1 |
0.0000 |
| 119 |
PAIN |
3 |
0.0000 |
| 120 |
HYPERTENSION |
1 |
0.0000 |
| 121 |
OVERDOSE |
1 |
0.0000 |
| 122 |
CONSTIPATION |
1 |
0.0000 |
| 123 |
WEIGHT INCREASED |
1 |
0.0000 |
| 124 |
DECREASED APPETITE |
1 |
0.0000 |
| 125 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 126 |
FEELING ABNORMAL |
1 |
0.0000 |
| 127 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 128 |
DIZZINESS |
2 |
0.0000 |
| 129 |
DYSPNOEA |
2 |
0.0000 |
| 130 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 131 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 132 |
DRUG INEFFECTIVE |
4 |
0.0000 |
| 133 |
OFF LABEL USE |
2 |
0.0000 |